.svg){kind=small}
Dr. Jorg Taubel will be attending the EPI | Lifestyle Scientific Sessions 2024. Taking place from 18th to 21st March in Chicago, Illinois, this event is a cornerstone for professionals in the field of epidemiology, prevention, and lifestyle medicine, with a particular focus on cardiometabolic health.
Dr. Taubel's presence at the conference promises to enrich the discussions and debates surrounding epidemiological cardiovascular issues and the impact of lifestyle trends. We anticipate engaging sessions that delve deep into understanding and addressing the intersection of lifestyle factors and cardiovascular health.
To find out more https://professional.heart.org/en/meetings/epi-lifestyle
#EPILifestyle24
-min.jpg)
.jpg)
Latest news
Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease
June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read moreA first of a kind trial in the fight against malaria
June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read moreEvents
AHA Hypertension Scientific Sessions 2024
5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event
